JACOBS DOUWE EGBERTS BR COMERCIALIZAÇÃO DE CAFÉS LTDA. – Trademark Portfolio
Entity Type: 99
JACOBS DOUWE EGBERTS BR COMERCIALIZAÇÃO DE CAFÉS LTDA. holds 1 U.S. trademark filed with the United States Patent and Trademark Office (USPTO), with a strong focus on Class 30 (Staple Foods) — 1 filings in this category. Currently, 1 trademark is registered. Notable registered marks include PILAO. The owner is based in BARUERI, SAO PAULO.
Av Dr Marcos Penteado de Ulhôa Rodrigues
No. 939, 2nd Floor
BARUERI, SAO PAULO 06460-040 , BR
Showing of trademarks Trademarks
Trademark Classifications
JACOBS DOUWE EGBERTS BR COMERCIALIZAÇÃO DE CAFÉS LTDA.'s trademark portfolio spans 1 Nice Classification class, reflecting the scope of goods and services protected under their brand portfolio.
Coffee, tea, cocoa and artificial coffee; rice; tapioca and sago; flour and preparations
Frequently Asked Questions
How many trademarks does JACOBS DOUWE EGBERTS BR COMERCIALIZAÇÃO DE CAFÉS LTDA. have?
JACOBS DOUWE EGBERTS BR COMERCIALIZAÇÃO DE CAFÉS LTDA. has 1 U.S. trademark filed with the USPTO. Of these, 1 registered.
What trademark classes does JACOBS DOUWE EGBERTS BR COMERCIALIZAÇÃO DE CAFÉS LTDA. file in?
JACOBS DOUWE EGBERTS BR COMERCIALIZAÇÃO DE CAFÉS LTDA. files trademarks across 1 Nice Classification class. The most active classes are Class 30 (Staple Foods). Class 30 covers coffee, tea, cocoa and artificial coffee; rice; tapioca and sago; flour and preparations.
What are JACOBS DOUWE EGBERTS BR COMERCIALIZAÇÃO DE CAFÉS LTDA.'s most well-known trademarks?
JACOBS DOUWE EGBERTS BR COMERCIALIZAÇÃO DE CAFÉS LTDA.'s registered trademark portfolio includes well-known marks such as PILAO. These are among 1 currently registered trademark in the portfolio.
What is JACOBS DOUWE EGBERTS BR COMERCIALIZAÇÃO DE CAFÉS LTDA.'s trademark registration success rate?
JACOBS DOUWE EGBERTS BR COMERCIALIZAÇÃO DE CAFÉS LTDA. has a 100% trademark registration rate, with 1 out of 1 resolved applications resulting in successful registration. Currently, 0 applications are pending review.